1361026-00-7

Upstream product

• 7357-66-6 N-(5-bromo-4-methoxy-2-nitrophenyl)acetamide 
• 372-20-3 3-fluorophenol 
• 160088-53-9 N-(5-chloro-4-methoxy-2-nitrophenyl)-acetamide 

Downstream Products

• 1620142-34-8 8-[(3-aminopropyl)amino]-6-methoxy-4-methyl-5-(3-fluorophenyloxy)quinoline 
• 1620142-35-9 4-{[5-(3-fluorophenoxy)-6-methoxy-4-methylquinolin-8-ylamino]methyl}phenol 
• 1628960-36-0 5-(3-fluorophenyloxy)-6-methoxy-4-methyl-8-(3-phthalimidopropylamino)quinoline 
• 1361025-64-0 C₃₀H₂₈FN₃O₄ 
• 106363-57-9 8-amino-5-(3-fluorophenyloxy)-6-methoxy-4-methylquinoline 
• 106363-62-6 5-(3-fluorophenyloxy)-6-methoxy-4-methyl-8-nitroquinoline 
• 1361025-88-8 C₁₃H₁₁FN₂O₄*ClH 
• 106363-54-6 C₄H₆O₄*C₂₂H₂₆FN₃O₂ 
• 106363-53-5 C₂₂H₂₆FN₃O₂ 

Relevant academic research and scientific papers

Syntheses, neural protective activities, and inhibition of glycogen synthase kinase-3β of substituted quinolines

A new series of fifteen 5-, 6-, and 8-appended 4-methylquinolines were synthesized and evaluated for their neural protective activities. Selected compounds were further examined for their inhibition of glycogen synthase kinase-3β (GSK-3β) and protein kina

Inhibition of human monoamine oxidase A and B by 5-phenoxy 8-aminoquinoline analogs

8-Aminoquinolines (8-AQs) are important class of anti-infective therapeutics. 5-Phenoxy 8-aminoquinoline analogs have shown improved metabolic stability compared to primaquine. In view or predictive role of monoamine oxidases (MAO) in metabolism of 8-amin